164 related articles for article (PubMed ID: 37848946)
1. KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations.
Wang K; Gong Z; Chen Y; Zhang M; Wang S; Yao S; Liu Z; Huang Z; Fei B
Clin Epigenetics; 2023 Oct; 15(1):163. PubMed ID: 37848946
[TBL] [Abstract][Full Text] [Related]
2. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
[TBL] [Abstract][Full Text] [Related]
3. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
Osman AA; Monroe MM; Ortega Alves MV; Patel AA; Katsonis P; Fitzgerald AL; Neskey DM; Frederick MJ; Woo SH; Caulin C; Hsu TK; McDonald TO; Kimmel M; Meyn RE; Lichtarge O; Myers JN
Mol Cancer Ther; 2015 Feb; 14(2):608-19. PubMed ID: 25504633
[TBL] [Abstract][Full Text] [Related]
4. Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells.
Bai J; Ma M; Cai M; Xu F; Chen J; Wang G; Shuai X; Tao K
Cell Prolif; 2014 Jun; 47(3):211-8. PubMed ID: 24738879
[TBL] [Abstract][Full Text] [Related]
5. Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity.
Fischer NW; Prodeus A; Gariépy J
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089713
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.
Wang J; Zheng X; Qin Z; Wei L; Lu Y; Peng Q; Gao Y; Zhang X; Zhang X; Li Z; Fu Y; Liu P; Liu C; Yan Q; Xiong W; Li G; Lu J; Ma J
J Biol Chem; 2019 Mar; 294(13):4854-4866. PubMed ID: 30674552
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis.
Pichavaram P; Jablonowski CM; Fang J; Fleming AM; Gil HJ; Boghossian AS; Rees MG; Ronan MM; Roth JA; Morton CL; Zambetti GP; Davidoff AM; Yang J; Murphy AJ
Mol Cancer Ther; 2024 Apr; 23(4):478-491. PubMed ID: 37988559
[TBL] [Abstract][Full Text] [Related]
8. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.
Rokutan H; Abe H; Nakamura H; Ushiku T; Arakawa E; Hosoda F; Yachida S; Tsuji Y; Fujishiro M; Koike K; Totoki Y; Fukayama M; Shibata T
J Pathol; 2019 Apr; 247(4):494-504. PubMed ID: 30474112
[TBL] [Abstract][Full Text] [Related]
9. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts.
Tahara T; Tahara S; Horiguchi N; Okubo M; Terada T; Yamada H; Yoshida D; Omori T; Osaki H; Maeda K; Kamano T; Funasaka K; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
Hum Mutat; 2019 Mar; 40(3):347-354. PubMed ID: 30575210
[TBL] [Abstract][Full Text] [Related]
11. CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
Chrisanthar R; Knappskog S; Løkkevik E; Anker G; Østenstad B; Lundgren S; Berge EO; Risberg T; Mjaaland I; Maehle L; Engebretsen LF; Lillehaug JR; Lønning PE
PLoS One; 2008 Aug; 3(8):e3062. PubMed ID: 18725978
[TBL] [Abstract][Full Text] [Related]
12. DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells.
Jackson TR; Salmina K; Huna A; Inashkina I; Jankevics E; Riekstina U; Kalnina Z; Ivanov A; Townsend PA; Cragg MS; Erenpreisa J
Cell Cycle; 2013 Feb; 12(3):430-41. PubMed ID: 23287532
[TBL] [Abstract][Full Text] [Related]
13. DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.
Malaquin N; Vancayseele A; Gilbert S; Antenor-Habazac L; Olivier MA; Ait Ali Brahem Z; Saad F; Delouya G; Rodier F
Cells; 2020 Jul; 9(7):. PubMed ID: 32630281
[TBL] [Abstract][Full Text] [Related]
14. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.
Lindemann A; Patel AA; Silver NL; Tang L; Liu Z; Wang L; Tanaka N; Rao X; Takahashi H; Maduka NK; Zhao M; Chen TC; Liu W; Gao M; Wang J; Frank SJ; Hittelman WN; Mills GB; Myers JN; Osman AA
Clin Cancer Res; 2019 Sep; 25(18):5650-5662. PubMed ID: 31308060
[TBL] [Abstract][Full Text] [Related]
15. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
[TBL] [Abstract][Full Text] [Related]
16. Clinical Relevance and Molecular Phenotypes in Gastric Cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations.
Park S; Lee J; Kim YH; Park J; Shin JW; Nam S
Sci Rep; 2016 Oct; 6():34822. PubMed ID: 27708434
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms.
Ernst P; Schnöder TM; Huber N; Perner F; Jayavelu AK; Eifert T; Hsu CJ; Tubío-Santamaría N; Crodel CC; Ungelenk M; Hübner CA; Clement JH; Hochhaus A; Heidel FH
Leukemia; 2022 Jul; 36(7):1843-1849. PubMed ID: 35654819
[TBL] [Abstract][Full Text] [Related]
18. Systematic Inspection of the Clinical Relevance of TP53 Missense Mutations in Gastric Cancer.
Moon S; Balch C; Park S; Lee J; Sung J; Nam S
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(5):1693-1701. PubMed ID: 29994072
[TBL] [Abstract][Full Text] [Related]
19. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-Saccà M
J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862
[TBL] [Abstract][Full Text] [Related]
20. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
Virchows Arch; 2019 Mar; 474(3):315-324. PubMed ID: 30554333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
